|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 217.12 USD | +3.52% |
|
+6.85% | +22.62% |
| 02/07 | Biogen Says Research, Milestone Charges to Reduce Earnings in Q2, Q3 | MT |
| 01/07 | HEALTH ROUNDS-Old cancer drug may help restore fertility for certain women | RE |
| Market Cap | 3.1TCr 2.72TCr 2.5TCr 2.33TCr 4.4TCr 2,94400Cr 4.49TCr 30TCr 12TCr 1,44500Cr 12TCr 11TCr 5,02900Cr | P/E 2026 * |
33.9x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.63TCr 3.19TCr 2.94TCr 2.74TCr 5.16TCr 3,45500Cr 5.27TCr 35TCr 14TCr 1,69600Cr 14TCr 13TCr 5,90200Cr | EV / Sales 2026 * |
3.61x | EV / Sales 2027 * | 3.31x |
| Free-Float |
85.96% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +3.27% | ||
| 1 week | +6.85% | ||
| Current month | -0.12% | ||
| 1 month | +14.28% | ||
| 3 months | +21.69% | ||
| 6 months | +21.36% | ||
| Current year | +22.62% |
| 1 week | 202.29 |  | 219.72 |
| 1 month | 187.48 | | 219.72 |
| Current year | 160.36 | | 219.72 |
| 1 year | 121.05 | | 219.72 |
| 3 years | 110.04 | | 287.6 |
| 5 years | 110.04 | | 372.12 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Guy Hadari
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Director | 1,505 | 0.0010% | ||
| 09/06 | Free | Chairman | 2,005 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.52% | +6.85% | +62.02% | -24.40% | 3.1TCr | |
| +2.95% | +3.08% | +16.70% | -10.98% | 6.36TCr | |
| +2.44% | +2.96% | +58.49% | +232.24% | 5.59TCr | |
| +0.36% | +39.60% | +39.60% | +39.60% | 4.17TCr | |
| -0.52% | +0.08% | -50.89% | -57.38% | 3.91TCr | |
| +7.45% | +31.92% | +160.30% | -35.25% | 2.88TCr | |
| +3.75% | +10.04% | +73.58% | +90.61% | 2.27TCr | |
| +7.22% | +12.16% | +7.63% | +184.50% | 1.76TCr | |
| +1.47% | +1.11% | +66.50% | +128.24% | 1.67TCr | |
| +2.35% | +9.57% | +78.29% | +340.12% | 1.46TCr | |
| Average | +3.07% | +4.95% | +51.22% | +88.73% | 3.32TCr | |
| Weighted average by Cap. | +2.73% | +3.98% | +43.97% | +67.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.01TCr 882.61Cr 812.41Cr 757.03Cr 1.43TCr 96TCr 1.46TCr 9.77TCr 3.79TCr 47TCr 3.77TCr 3.69TCr 1,63300Cr | 1.04TCr 911.48Cr 838.98Cr 781.79Cr 1.47TCr 99TCr 1.5TCr 10TCr 3.91TCr 48TCr 3.9TCr 3.81TCr 1,68600Cr |
| Net income | 152.22Cr 133.65Cr 123.02Cr 114.63Cr 216.19Cr 14TCr 220.58Cr 1.48TCr 573.28Cr 7.1TCr 571.54Cr 559.18Cr 25TCr | 196.89Cr 172.87Cr 159.12Cr 148.27Cr 279.63Cr 19TCr 285.31Cr 1.91TCr 741.5Cr 9.19TCr 739.26Cr 723.27Cr 32TCr |
| Net Debt | 537.21Cr 471.67Cr 434.15Cr 404.56Cr 762.97Cr 51TCr 778.47Cr 5.22TCr 2.02TCr 25TCr 2.02TCr 1.97TCr 87TCr | 334.98Cr 294.12Cr 270.72Cr 252.27Cr 475.76Cr 32TCr 485.43Cr 3.26TCr 1.26TCr 16TCr 1.26TCr 1.23TCr 54TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $215.80 | +2.89% | 1,34,063 |
| 01/26/01 | $209.74 | -2.93% | 11,38,639 |
| 30/26/30 | $216.06 | -0.26% | 10,91,325 |
| 29/26/29 | $216.63 | +0.28% | 12,79,990 |
| 26/26/26 | $216.03 | +6.97% | 23,74,525 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
